News | Proton Therapy | April 09, 2019

Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment

First preclinical results with ultra-high-dose proton therapy presented at AACR

Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment

April 9, 2019 — Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the Maryland Proton Treatment Center, presented publicly the first pre-clinical results of its research on ultra-high-dose rate cancer treatments with protons. Known as Flash therapy, it is a non-invasive therapy for cancer delivering high doses of radiation in ultra-high-speeds (less than 1 second) and represents the potential for a major breakthrough in the treatment of cancer. The preclinical Flash therapy results — presented at the American Association for Cancer Research (AACR) annual meeting, March 29-April 3 in Atlanta — showed reduced toxicity in healthy tissues and organs.

Conducted on a clinical device capable of translation to humans, the Flash therapy preclinical tests, compared to conventional proton treatments, displayed 25-30 percent less damage to lung tissue, resulting in less fibrosis of the lung, and an average of 35 percent reduction in skin dermatitis during treatment.

The FlashForward Consortium, comprised of 14 cancer centers, is focused on preclinical research, clinical implementation and advocacy efforts of Flash therapy. Working groups in the FlashForward Consortium are identifying preclinical study design for understanding this therapy, developing and sharing protocols that will enable a safe and quality clinical start for new users, and assist with regulatory and advocacy efforts.

“Partnering with Varian’s Global Translational Science team on the first proton Flash pre-clinical study, and being one of the founding members of the FlashForward Consortium, is a significant step in building a foundation of research and bridging the gap to patient benefits in this potentially game-changing therapy,” said William F. Regine, M.D., The Isadore & Fannie Foxman Chair and professor, Department of Radiation Oncology at the University of Maryland School of Medicine, and executive director of the Maryland Proton Treatment Center. The pre-clinical study was led by Zeljko Vujaskovic, M.D., Ph.D., professor of radiation oncology and director of the Division of Translational Radiation Services, and Lauren Jackson, Ph.D., associate professor of radiation oncology and deputy director of translational radiation sciences.

Read more about the data presented at AACR here.

For more information:

Related Content

AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
RaySearch Releases Version 3A of RayCare Oncology Information System
Technology | Oncology Information Management Systems (OIMS) | July 15, 2019
RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is...
IBA Launches Monte Carlo Patient QA for Varian Halcyon at AAPM 2019
Technology | Quality Assurance (QA) | July 10, 2019
IBA announced the launch of the latest functionality of the SciMoCa Monte Carlo Patient QA solution at the 61st annual...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

News | Quality Assurance (QA) | July 08, 2019
At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio, Texas, PTW will...
Aktina Medical Partners With Elekta for Global Distribution of Interlocking SRS Cones
News | Radiation Therapy | July 05, 2019
Aktina Medical announced that Elekta Instrument AB, based in Sweden, will offer and distribute the Aktina line of...
Civco Displaying Universal Couchtop ProForm Head & Neck Solution at AAPM
News | Patient Positioning Radiation Therapy | July 03, 2019
The upcoming release of Civco’s Universal Couchtop ProForm Head & Neck Solution will allow proton therapy centers...
RaySearch Releases Version 9A of RayStation Treatment Planning System
Technology | Treatment Planning | July 02, 2019
RaySearch announced the release of RayStation 9A, the latest version of its radiation therapy treatment planning system...
Philips Pinnacle

Image courtesy of Philips Healthcare

Feature | Treatment Planning | July 01, 2019 | By Jeff Zagoudis